House E&C Subcommittee on Health Holds Another Hearing on Health Care Affordability
The House Committee on Energy and Commerce Subcommittee on Health held another hearing on June 10 in its affordability series to explore more...
The Centers for Medicare & Medicaid Services (CMS) is expanding Medicare coverage for genetic testing through the MolDX program administered by Palmetto GBA.
CMS announced two new local coverage determinations (LCDs) to cover diagnostic tests used to evaluate and manage care for patients suspected of having hereditary transthyretin amyloidosis:
- Genetic Testing for Heritable Thoracic Aortic Disease (L39933)
- Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis (L39935)
The LCDs will take effect Aug. 17 in 23 states.
Source:
https://www.cap.org/advocacy/latest-news-and-practice-data/july-8-2025
TELCOR POC Device Connectivity Updates -2026 Q1
Lincoln, NE - June 16, 2026 TELCOR QML® has connectivity for more than 160 device types. Whether you are looking to add new testing on devices...
TELCOR Brings New Operator Management Capabilities to ADLM 2026
Lincoln, NE – June 12, 2026 – TELCOR Inc, the industry leader in healthcare software for point of care testing and laboratory revenue cycle...